Urological cancer, Malmö
401 – 410 of 555
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
- Contribution to journal › Scientific review
-
Mark
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
- Contribution to journal › Scientific review
-
Mark
CRISP-3 AND B-MSP ON PROSTATE CANCER NEEDLE-BIOPSIES DO NOT HAVE PREDICTIVE VALUE FOR SUBSEQUENT PROSTATECTOMY OUTCOME
(2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.237-238
- Contribution to journal › Published meeting abstract
-
Mark
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
- Contribution to journal › Scientific review
-
Mark
Translational perspectives on MSMB and CRISP3 expression and regulation in prostate cancer
- Thesis › Doctoral thesis (compilation)
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- Contribution to journal › Article
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
- Contribution to journal › Article
-
Mark
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
- Contribution to journal › Article
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
- Contribution to journal › Article
-
Mark
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
- Contribution to journal › Article
